Noninvasive Prenatal Diagnostics Market - Global Outlook and Forecast 2022-2028

March 2022 | 60 pages | ID: N891C421720CEN
Market Monitor Global

Abstracts

Noninvasive Prenatal Diagnostics detect a variety of chromosomal disorders such as Down's syndrome, Edwards syndrome, Turner syndrome and Pato syndrome.

This report contains market size and forecasts of Noninvasive Prenatal Diagnostics in Global, including the following market information:

Global Noninvasive Prenatal Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Noninvasive Prenatal Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Services Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Noninvasive Prenatal Diagnostics include Natera, Illumina, BGI Diagnosis, Ariosa Diagnostics, Quest Diagnostics, Premaitha Health, NIPD Genetics, Labcorp and Ravgen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Noninvasive Prenatal Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Noninvasive Prenatal Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Noninvasive Prenatal Diagnostics Market Segment Percentages, by Type, 2021 (%)

• Services
• Instrument

Global Noninvasive Prenatal Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Noninvasive Prenatal Diagnostics Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Personal
• Other

Global Noninvasive Prenatal Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Noninvasive Prenatal Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Noninvasive Prenatal Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Noninvasive Prenatal Diagnostics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Natera
• Illumina
• BGI Diagnosis
• Ariosa Diagnostics
• Quest Diagnostics
• Premaitha Health
• NIPD Genetics
• Labcorp
• Ravgen
• LifeCodexx
• TrovaGene
• Quest Diagnostics
• Berry Genomics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Noninvasive Prenatal Diagnostics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Noninvasive Prenatal Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NONINVASIVE PRENATAL DIAGNOSTICS OVERALL MARKET SIZE

2.1 Global Noninvasive Prenatal Diagnostics Market Size: 2021 VS 2028
2.2 Global Noninvasive Prenatal Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Noninvasive Prenatal Diagnostics Players in Global Market
3.2 Top Global Noninvasive Prenatal Diagnostics Companies Ranked by Revenue
3.3 Global Noninvasive Prenatal Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Noninvasive Prenatal Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Noninvasive Prenatal Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Noninvasive Prenatal Diagnostics Players in Global Market
  3.6.1 List of Global Tier 1 Noninvasive Prenatal Diagnostics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Noninvasive Prenatal Diagnostics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Noninvasive Prenatal Diagnostics Market Size Markets, 2021 & 2028
  4.1.2 Services
  4.1.3 Instrument
4.2 By Type - Global Noninvasive Prenatal Diagnostics Revenue & Forecasts
  4.2.1 By Type - Global Noninvasive Prenatal Diagnostics Revenue, 2017-2022
  4.2.2 By Type - Global Noninvasive Prenatal Diagnostics Revenue, 2023-2028
  4.2.3 By Type - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Noninvasive Prenatal Diagnostics Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Personal
  5.1.4 Other
5.2 By Application - Global Noninvasive Prenatal Diagnostics Revenue & Forecasts
  5.2.1 By Application - Global Noninvasive Prenatal Diagnostics Revenue, 2017-2022
  5.2.2 By Application - Global Noninvasive Prenatal Diagnostics Revenue, 2023-2028
  5.2.3 By Application - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Noninvasive Prenatal Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Noninvasive Prenatal Diagnostics Revenue & Forecasts
  6.2.1 By Region - Global Noninvasive Prenatal Diagnostics Revenue, 2017-2022
  6.2.2 By Region - Global Noninvasive Prenatal Diagnostics Revenue, 2023-2028
  6.2.3 By Region - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Noninvasive Prenatal Diagnostics Revenue, 2017-2028
  6.3.2 US Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.3.3 Canada Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.3.4 Mexico Noninvasive Prenatal Diagnostics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Noninvasive Prenatal Diagnostics Revenue, 2017-2028
  6.4.2 Germany Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.4.3 France Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.4.4 U.K. Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.4.5 Italy Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.4.6 Russia Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.4.7 Nordic Countries Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.4.8 Benelux Noninvasive Prenatal Diagnostics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Noninvasive Prenatal Diagnostics Revenue, 2017-2028
  6.5.2 China Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.5.3 Japan Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.5.4 South Korea Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.5.5 Southeast Asia Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.5.6 India Noninvasive Prenatal Diagnostics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Noninvasive Prenatal Diagnostics Revenue, 2017-2028
  6.6.2 Brazil Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.6.3 Argentina Noninvasive Prenatal Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Noninvasive Prenatal Diagnostics Revenue, 2017-2028
  6.7.2 Turkey Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.7.3 Israel Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.7.4 Saudi Arabia Noninvasive Prenatal Diagnostics Market Size, 2017-2028
  6.7.5 UAE Noninvasive Prenatal Diagnostics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Natera
  7.1.1 Natera Corporate Summary
  7.1.2 Natera Business Overview
  7.1.3 Natera Noninvasive Prenatal Diagnostics Major Product Offerings
  7.1.4 Natera Noninvasive Prenatal Diagnostics Revenue in Global Market (2017-2022)
  7.1.5 Natera Key News
7.2 Illumina
  7.2.1 Illumina Corporate Summary
  7.2.2 Illumina Business Overview
  7.2.3 Illumina Noninvasive Prenatal Diagnostics Major Product Offerings
  7.2.4 Illumina Noninvasive Prenatal Diagnostics Revenue in Global Market (2017-2022)
  7.2.5 Illumina Key News
7.3 BGI Diagnosis
  7.3.1 BGI Diagnosis Corporate Summary
  7.3.2 BGI Diagnosis Business Overview
  7.3.3 BGI Diagnosis Noninvasive Prenatal Diagnostics Major Product Offerings
  7.3.4 BGI Diagnosis Noninvasive Prenatal Diagnostics Revenue in Global Market (2017-2022)
  7.3.5 BGI Diagnosis Key News
7.4 Ariosa Diagnostics
  7.4.1 Ariosa Diagnostics Corporate Summary
  7.4.2 Ariosa Diagnostics Business Overview
  7.4.3 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Major Product Offerings
  7.4.4 Ariosa Diagnostics Noninvasive Prenatal Diagnostics Revenue in Global Market (2017-2022)
  7.4.5 Ariosa Diagnostics Key News
7.5 Quest Diagnostics
  7.5.1 Quest Diagnostics Corporate Summary
  7.5.2 Quest Diagnostics Business Overview
  7.5.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Major Product Offerings
  7.5.4 Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue in Global Market (2017-2022)
  7.5.5 Quest Diagnostics Key News
7.6 Premaitha Health
  7.6.1 Premaitha Health Corporate Summary
  7.6.2 Premaitha Health Business Overview
  7.6.3 Premaitha Health Noninvasive Prenatal Diagnostics Major Product Offerings
  7.6.4 Premaitha Health Noninvasive Prenatal Diagnostics Revenue in Global Market (2017-2022)
  7.6.5 Premaitha Health Key News
7.7 NIPD Genetics
  7.7.1 NIPD Genetics Corporate Summary
  7.7.2 NIPD Genetics Business Overview
  7.7.3 NIPD Genetics Noninvasive Prenatal Diagnostics Major Product Offerings
  7.7.4 NIPD Genetics Noninvasive Prenatal Diagnostics Revenue in Global Market (2017-2022)
  7.7.5 NIPD Genetics Key News
7.8 Labcorp
  7.8.1 Labcorp Corporate Summary
  7.8.2 Labcorp Business Overview
  7.8.3 Labcorp Noninvasive Prenatal Diagnostics Major Product Offerings
  7.8.4 Labcorp Noninvasive Prenatal Diagnostics Revenue in Global Market (2017-2022)
  7.8.5 Labcorp Key News
7.9 Ravgen
  7.9.1 Ravgen Corporate Summary
  7.9.2 Ravgen Business Overview
  7.9.3 Ravgen Noninvasive Prenatal Diagnostics Major Product Offerings
  7.9.4 Ravgen Noninvasive Prenatal Diagnostics Revenue in Global Market (2017-2022)
  7.9.5 Ravgen Key News
7.10 LifeCodexx
  7.10.1 LifeCodexx Corporate Summary
  7.10.2 LifeCodexx Business Overview
  7.10.3 LifeCodexx Noninvasive Prenatal Diagnostics Major Product Offerings
  7.10.4 LifeCodexx Noninvasive Prenatal Diagnostics Revenue in Global Market (2017-2022)
  7.10.5 LifeCodexx Key News
7.11 TrovaGene
  7.11.1 TrovaGene Corporate Summary
  7.11.2 TrovaGene Business Overview
  7.11.3 TrovaGene Noninvasive Prenatal Diagnostics Major Product Offerings
  7.11.4 TrovaGene Noninvasive Prenatal Diagnostics Revenue in Global Market (2017-2022)
  7.11.5 TrovaGene Key News
7.12 Quest Diagnostics
  7.12.1 Quest Diagnostics Corporate Summary
  7.12.2 Quest Diagnostics Business Overview
  7.12.3 Quest Diagnostics Noninvasive Prenatal Diagnostics Major Product Offerings
  7.12.4 Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue in Global Market (2017-2022)
  7.12.5 Quest Diagnostics Key News
7.13 Berry Genomics
  7.13.1 Berry Genomics Corporate Summary
  7.13.2 Berry Genomics Business Overview
  7.13.3 Berry Genomics Noninvasive Prenatal Diagnostics Major Product Offerings
  7.13.4 Berry Genomics Noninvasive Prenatal Diagnostics Revenue in Global Market (2017-2022)
  7.13.5 Berry Genomics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Noninvasive Prenatal Diagnostics Market Opportunities & Trends in Global Market
Table 2. Noninvasive Prenatal Diagnostics Market Drivers in Global Market
Table 3. Noninvasive Prenatal Diagnostics Market Restraints in Global Market
Table 4. Key Players of Noninvasive Prenatal Diagnostics in Global Market
Table 5. Top Noninvasive Prenatal Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Noninvasive Prenatal Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Noninvasive Prenatal Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Noninvasive Prenatal Diagnostics Product Type
Table 9. List of Global Tier 1 Noninvasive Prenatal Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Noninvasive Prenatal Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Noninvasive Prenatal Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Noninvasive Prenatal Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Noninvasive Prenatal Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Noninvasive Prenatal Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Noninvasive Prenatal Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Noninvasive Prenatal Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Natera Corporate Summary
Table 31. Natera Noninvasive Prenatal Diagnostics Product Offerings
Table 32. Natera Noninvasive Prenatal Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Illumina Corporate Summary
Table 34. Illumina Noninvasive Prenatal Diagnostics Product Offerings
Table 35. Illumina Noninvasive Prenatal Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. BGI Diagnosis Corporate Summary
Table 37. BGI Diagnosis Noninvasive Prenatal Diagnostics Product Offerings
Table 38. BGI Diagnosis Noninvasive Prenatal Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Ariosa Diagnostics Corporate Summary
Table 40. Ariosa Diagnostics Noninvasive Prenatal Diagnostics Product Offerings
Table 41. Ariosa Diagnostics Noninvasive Prenatal Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Quest Diagnostics Corporate Summary
Table 43. Quest Diagnostics Noninvasive Prenatal Diagnostics Product Offerings
Table 44. Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Premaitha Health Corporate Summary
Table 46. Premaitha Health Noninvasive Prenatal Diagnostics Product Offerings
Table 47. Premaitha Health Noninvasive Prenatal Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. NIPD Genetics Corporate Summary
Table 49. NIPD Genetics Noninvasive Prenatal Diagnostics Product Offerings
Table 50. NIPD Genetics Noninvasive Prenatal Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Labcorp Corporate Summary
Table 52. Labcorp Noninvasive Prenatal Diagnostics Product Offerings
Table 53. Labcorp Noninvasive Prenatal Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Ravgen Corporate Summary
Table 55. Ravgen Noninvasive Prenatal Diagnostics Product Offerings
Table 56. Ravgen Noninvasive Prenatal Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. LifeCodexx Corporate Summary
Table 58. LifeCodexx Noninvasive Prenatal Diagnostics Product Offerings
Table 59. LifeCodexx Noninvasive Prenatal Diagnostics Revenue (US$, Mn), (2017-2022)
Table 60. TrovaGene Corporate Summary
Table 61. TrovaGene Noninvasive Prenatal Diagnostics Product Offerings
Table 62. TrovaGene Noninvasive Prenatal Diagnostics Revenue (US$, Mn), (2017-2022)
Table 63. Quest Diagnostics Corporate Summary
Table 64. Quest Diagnostics Noninvasive Prenatal Diagnostics Product Offerings
Table 65. Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue (US$, Mn), (2017-2022)
Table 66. Berry Genomics Corporate Summary
Table 67. Berry Genomics Noninvasive Prenatal Diagnostics Product Offerings
Table 68. Berry Genomics Noninvasive Prenatal Diagnostics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Noninvasive Prenatal Diagnostics Segment by Type in 2021
Figure 2. Noninvasive Prenatal Diagnostics Segment by Application in 2021
Figure 3. Global Noninvasive Prenatal Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Noninvasive Prenatal Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Noninvasive Prenatal Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Noninvasive Prenatal Diagnostics Revenue in 2021
Figure 8. By Type - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Noninvasive Prenatal Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Noninvasive Prenatal Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Noninvasive Prenatal Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Noninvasive Prenatal Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Noninvasive Prenatal Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Noninvasive Prenatal Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Noninvasive Prenatal Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Natera Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Illumina Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. BGI Diagnosis Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Ariosa Diagnostics Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Premaitha Health Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. NIPD Genetics Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Labcorp Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Ravgen Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. LifeCodexx Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. TrovaGene Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Quest Diagnostics Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Berry Genomics Noninvasive Prenatal Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)